Br. J. Cancer 2013 Feb 05
Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy.
ABSTRACT
BACKGROUND
To investigate the issue of timing of radiation therapy (RT) after lumpectomy in relation to recurrences and outcome.
METHODS
Analysis was done on 1107 breast-conserving therapies (BCT) with 1070 women, all without lymph node metastasis and without any adjuvant systemic therapy. Timing was defined as time from lumpectomy till RT. Patients were categorised into tertiles: <45 days, 45-56 days, and 57-112 days.
RESULTS
Local control did not show a difference between the tertiles. The distant metastasis-free survival as well as the disease-specific survival showed a decreased outcome starting the RT to early after the lumpectomy.
CONCLUSION
The results of this cohort study further refines the hypothesis that timing of RT in BCT might have an impact on outcome. It suggests that a randomised trial in timing of RT in BCT seems necessary to give a definite answer.
Related Questions
Would your practice vary based on hormone receptor or Her2 status?
New answer by Radiation Oncologist at Coastal Radiation Oncology (March 24, 2020)
How will you prioritize new starts when the COVID-19 pandemic is over and you have a backlog of delayed patients and newly diagnosed patients to schedule?